This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Study to Assess Whether Etrolizumab is a Safe an...
Clinical trial

A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD) (BERGAMOT)

Read time: 3 mins
Last updated:20th Mar 2015
Identifier: NCT02394028
Register free for full access to medthority.com